Geraldina Lionetti, MD

Dr. Lionetti is a board-certified pediatric rheumatologist committed to treating children, teens, and young adults with rheumatic disease. She completed her Pediatric internship and residency at Children's Hospital Los Angeles and her Pediatric Rheumatology fellowship at Stanford University. She serves as the Medical Director and Section Chief of the Pediatric Rheumatology division at UCSF Benioff Children’s Oakland.
Her clinical work focuses on improving outcomes for children with rheumatic diseases through comprehensive evaluations and individualized treatment plans, with the goal of reducing morbidity so they may enter adulthood unhindered by their disease. Her primary areas of interest include mitigating treatment-related sequelae, auto-inflammatory disorders, improved access to subspecialty care, and resident education. To ensure adequate access to care, she also sees patients in the Walnut Creek outreach clinic and is involved in developing a telehealth program.
Clinics:
UCSF Benioff Children’s Hospital Oakland
744 52nd Street, OPC I, 5th Floor
Oakland, CA 94609
Walnut Creek location:
2401 Shadelands Drive
Walnut Creek, CA
Publications
  1. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.
  2. Consensus treatment plans for periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome (PFAPA): a framework to evaluate treatment responses from the childhood arthritis and rheumatology research alliance (CARRA) PFAPA work group.
  3. Physicians' perspectives on the diagnosis and management of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome.
  4. Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases.
  5. Using registries to identify adverse events in rheumatic diseases.
  6. IL-1 blockade as a novel approach to treatment of hyperzincemia and hypercalprotectinemia, a possible new autoinflammatory syndrome.
  7. Autoinflammatory Diseases in the Neonate: Mimickers of Neonatal Infections.